Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Study on Determine the Expression of the Furin Protein in Patients With Confirmed COVID-19 Disease (in Various Phases of the Disease), Recovered From SARS-CoV-2 and Vaccinated Against Coronavirus (All Types of Vaccines)

NCT05104840 is registered in ClinicalTrials.gov with Center Trials & Treatment as lead sponsor.

NCT NCT05104840
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05104840 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Study on Determine the Expression of the Furin Protein in Patients With Confirmed COVID-19 Disease (in Various Phases of the Disease), Recovered From SARS-CoV-2 and Vaccinated Against Coronavirus (All Types of Vaccines)
Lead sponsor
Center Trials & Treatment
Phase
Observational
Overall status
Terminated
Start date
August 10, 2022
Completion date
March 28, 2023
Enrollment
2,432 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19, furin, paired basic amino acid cleaving enzyme (pace), rgmc processing, sars-cov-2